U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Among the 2,225 adults in the study, all under 60 years of age, 39.7% had obesity as defined only by higher BMI, while 39.1% ...

A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

A clinical practice guideline that stresses a multidisciplinary approach is intended to help clinicians manage obesity in ...

India faces a growing liver disease crisis linked to obesity and diabetes, affecting even non-drinkers. Experts warn that ...

The drugmaker said Tuesday that it would stop studying danuglipron after a participant in one of its trials experienced a ...

Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient ...

With more than half of Chinese adults now classified as overweight, health authorities are stepping up measures to get people ...

A group of Democratic senators are calling on Health and Human Services Secretary Robert F. Kennedy Jr. to keep a proposed ...

New research being presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that ...